参考文献/References:
[1] Imagawa A,Hanafusa T,Miyagawa J,et al. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies[J].N Engl J Med,2000,342(5):301-307.DOI:10.1056/NEJM200002033420501.
[2] Larger É,Diedisheim M,Donath X,et al. Diagnostic circumstances and clinical forms of type 1 diabetes[J].Rev Prat,2018,68(6):614-618.
[3] Roden M. Diabetes mellitus definition,classification and diagnosis[J].Wien Klin Wochenschr,2016,128(Suppl 2):S37-S40.DOI:10.1007/s00508-015-0931-3.
[4] DiMeglio LA,Evans-Molina C,Oram RA.Type 1 diabetes[J]. Lancet,2018,391(10138):2449-2462.DOI:10.1016/S0140-6736(18)31320-5.
[5] Imagawa A,Hanafusa T,Uchigata Y,et al. Different contribution of class Ⅱ HLA in fulminant and typical autoimmune type 1 diabetes mellitus[J].Diabetologia,2005,48(2):294-300.DOI:10.1007/s00125-004-1626-x.
[6] Inokuchi R,Matsumoto A,Odajima H,et al. Fulminant type 1 diabetes mellitus[J].BMJ Case Rep,2012,2012:bcr 2012006560.DOI:10.1136/bcr-2012-006560.
[7] Rekik NM,Kamoun M,Mnif F,et al. Type 1 diabetes mellitus and Rett syndrome:is there a link?[J].J Endocrinol Invest,2010,33(11):851.DOI:10.1007/BF03350352.
[8] Liu L,Jia W,Liu R,et al. Clinical study of pregnancy-associated fulminant type 1 diabetes[J].Endocrine,2018,60(2):301-307.DOI:10.1007/s12020-018-1556-x.
[9] Imagawa A,Hanafusa T. Fulminant type1 diabetes-an important subtype in East Asia[J].Diabetes Metab Res Rev,2011,27(8):959-964.DOI:10.1002/dmrr.1236.
[10] Hosokawa Y,Hanafusa T,Imagawa A. Pathogenesis of fulminant type 1 diabetes:genes, viruses and the immune mechanism, and usefulness of patient-derived induced pluripotent stem cells for future research[J].J Diabetes Investig,2019,10(5):1158-1164.DOI:10.1111/jdi.13091.
[11] Murase Y,Imagawa A,Hanafusa T,et al. Fulminant type 1 diabetes as a high risk group for diabetic microangiopathy-a nationwide 5-year-study in Japan[J].Diabetologia,2007,50(3):531-537.DOI:10.1007/s00125-006-0575-y.
[12] Shibasaki S,Imagawa A,Hanafusa T,et al. Fulminant type 1 diabetes mellitus:a new class of type 1 diabetes[J].Adv Exp Med Biol,2012,771:20-23.DOI:10.1007/978-1-4614-5441-0_3.
[13] 何艳,李舍予,田浩明,等. 暴发性1型糖尿病和经典自身免疫性1型糖尿病的临床特征比较研究[J].生物医学工程学杂志,2013,30(3):597-600.DOI:10.7507/1001-5515.20130112.
[14] Carr RM,Oranu A,Khungar V. Nonalcoholic fatty liver disease:pathophysiology and management[J].Gastroenterol Clin North Am,2016,45(4):639-652.DOI:10.1016/j.gtc.2016.07.003.
[15] Sweet PH,Khoo T,Nguyen S.Nonalcoholic fatty liver disease[J].Prim Care,2017,44(4):599-607.DOI:10.1016/j.pop.2017.07.003.
[16] Badaloo A,Reid M,Soares D,et al. Relation between liver fat content and the rate of VLDL apolipoprotein B-100 synthesis in children with protein-energy malnutrition[J].Am J Clin Nutr,2005,81(5):1126-1132.DOI:10.1093/ajcn/81.5.1126.